Polyglutamine expansion disturbs the endoplasmic reticulum formation, leading to caspase-7 activation through Bax-Reference-Cited by-同舟云学术

Polyglutamine expansion disturbs the endoplasmic reticulum formation, leading to caspase-7 activation through Bax

Published:2014-01 Issue:4 Volume:443 Page:1232-1238
ISSN:0006-291X
Container-title:Biochemical and Biophysical Research Communications
language:en
Short-container-title:Biochemical and Biophysical Research Communications

Author:

Ueda Masashi,Li Shimo,Itoh Masanori,Hayakawa-Yano Yoshika,Wang Miao-xing,Hayakawa Miki,Hasebe-Matsubara Ryoko,Ohta Kazunori,Ohta Eri,Mizuno Akihito,Hida Yoko,Matsumoto Munekazu,Chen Huayue,Nakagawa Toshiyuki

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry,Biophysics

Reference26 articles.

1. Diversity in the mechanisms of neuronal cell death;Yuan;Neuron,2003

2. The BCL-2 protein family: opposing activities that mediate cell death;Youle;Nat. Rev. Mol. Cell Biol.,2008

3. Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta;Nakagawa;Nature,2000

4. Bax and Bak can localize to the endoplasmic reticulum to initiate apoptosis;Zong;J. Cell Biol.,2003

5. Translocation of C. elegans CED-4 to nuclear membranes during programmed cell death;Chen;Science,2000

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. miR-34a-5p as molecular hub of pathomechanisms in Huntington’s disease;Molecular Medicine;2023-04-03

2. Neurodegenerative Diseases: From Dysproteostasis, Altered Calcium Signalosome to Selective Neuronal Vulnerability to AAV-Mediated Gene Therapy;International Journal of Molecular Sciences;2022-11-16

3. New Approaches in Studies of the Molecular Pathogenesis of Type 2 Spinocerebellar Ataxia;Neuroscience and Behavioral Physiology;2020-09

4. SUMOylation Prevents Huntingtin Fibrillization and Localization onto Lipid Membranes;ACS Chemical Neuroscience;2019-12-27

5. Molecular Mechanisms and Therapeutics for Spinocerebellar Ataxia Type 2;Neurotherapeutics;2019-08-21